← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 30, 2015Last known activity
Sep 2, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06362837CollaboratorN/ASep 2, 2024
- NCT06405360CollaboratorN/AMay 2, 2024
- NCT06815315Lead sponsorN/AJan 1, 2024
- NCT02509494CollaboratorPhase 3Sep 30, 2015
Details
- Last known activity
- Sep 2, 2024